Oral Oncology

Papers
(The H4-Index of Oral Oncology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma351
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model98
Authors reply to the comment on: Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: A systematic review and meta-analysis75
Radiation-induced osteosarcoma in the head and neck region: Case report and literature review55
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?51
A single-cell sequencing-based analysis of a 13-year-old with maxillary sinus NUT carcinoma51
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study50
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review47
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients47
Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 239
Editorial Board/Aims & Scope36
P28 Head and neck cancer cells differentiate resembling their tissue of origin35
The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders34
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies32
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]32
Restoring the anti-tumor property of PTEN: A promising oral cancer treatment31
Comment on “Extensive necrosis of the tongue as a very early adverse event of head and neck radiotherapy”31
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD)31
Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study30
The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis29
Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database29
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection28
Effective, efficient palliative radiotherapy for advanced head and neck cancer: Real world data using 25 Gy in 5 fractions28
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection28
Radiation-induced sarcomas of the craniofacial region: A systematic review28
Squamous odontogenic tumor like proliferations in dentigerous cyst- a great mimicker27
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma27
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus–related malignancies27
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study27
Corrigendum to “Epigenetics: Promising journey so far but ways to go in head neck cancer” [Oral Oncol. 135 (2022) 106194]27
Rare mandibular metastasis of Ewing sarcoma presenting as an endodontic infection27
0.17151808738708